Drug Database
Back to search

Norway· NO-ID_060D6616-9941-4281-9781-58A4932877F3

ProHance

A gadoteridol product containing gadoteridol, registered in Norway by Bracco International B.V.. The same ATC class is registered in 14 of our 19 countries.

ATC V08CA04

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedProHanceATCV08CA04REGISTER NO.NO-ID_060D6616-9941-4…PACKS LISTED9CHECKEDSeptember 25, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about gadoteridolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Gadoteridol is registered in 14 of 19 countries.

Countries holding a registration under ATC V08CA04 (gadoteridol), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose
Search gadoteridol products by name

Gadoteridol · ATC V08CA04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FEST (Norway)
Active substance
Gadoteridol
Manufacturer
Bracco International B.V.
Country
Norway (NO)
ATC code
V08CA04
ATC class
Gadoteridol
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
September 25, 2026

Packs & prices · 9

4 priced
  • no_merkevare_id
    ID_060D6616-9941-4281-9781-58A4932877F3
  • gtin
    8032953585275
  • gtin
    8032953585251
  • gtin
    8032953585282
  • gtin
    8032953585268
  • no_varenummer
    539411
    10 x 20
    NOK 6629.4
  • no_varenummer
    539437
    10 x 10
    NOK 3332.8
  • no_varenummer
    103898
    50
    NOK 1958.7
  • no_varenummer
    539445
    10 x 15
    NOK 4981.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for gadoteridol.

Graded by severity as the source publishes them — 19 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check gadoteridol against other medicinesHow interaction checks work

Gadoteridol · interactions on record

19 records

  • 19 moderate

Most severe, free to view

  • PindololC07AA03moderate
  • PropranololC07AA05moderate
  • TimololC07AA06moderate
  • SotalolC07AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Gadoteridol in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All gadoteridol products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Prohance
  • Belgium · Prohance
  • Czechia · Prohance
  • Germany · Prohance
  • Denmark · Prohance
  • Estonia · Prohance
  • Spain · Prohance
  • Finland · Prohance
  • France · Prohance
  • United Kingdom (Northern Ireland) · Prohance
  • Greece · Prohance
  • Croatia · Prohance
  • Hungary · Prohance
  • Ireland · Prohance
  • Italy · Prohance
  • Lithuania · Prohance
  • Luxembourg · Prohance
  • Latvia · Prohance
  • Netherlands · Prohance
  • Poland · Prohance
  • Portugal · Prohance
  • Romania · Prohance
  • Sweden · Prohance
  • Slovenia · Prohance
  • Slovakia · Prohance

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f33e082c-04ac-42be-a226-73e13c54e0a7
GET /v1/drugs/f33e082c-04ac-42be-a226-73e13c54e0a7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Injeksjonsvæske, oppløsning",
  "source": "fest",
  "status": "A",
  "atc_name": "Gadoteridol",
  "merkevare_id": "ID_060D6616-9941-4281-9781-58A4932877F3",
  "name_form_strength": "ProHance inj, oppl 279,3 mg/ml",
  "prescription_group": "C"
}
API referenceMCP serverPlans

See everything about gadoteridol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console